Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)
PHASE1CompletedINTERVENTIONAL
Enrollment
12
Participants
Timeline
Start Date
February 28, 2007
Study Completion Date
February 28, 2007
Conditions
Depressive Disorder, Major
Interventions
DRUG
Desvenlafaxine Sustained Release (DVS SR)
Trial Locations (1)
02135
Boston
All Listed Sponsors
lead
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
NCT00440427 - Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR) | Biotech Hunter | Biotech Hunter